SunLink Health Systems (SSY)
(Delayed Data from AMEX)
$0.64 USD
-0.02 (-3.02%)
Updated May 3, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for SunLink Health Systems, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 48 | 41 | 41 | 48 | 46 |
Cost Of Goods | 24 | 21 | 19 | 23 | 23 |
Gross Profit | 24 | 20 | 22 | 25 | 23 |
Selling & Adminstrative & Depr. & Amort Expenses | 26 | 25 | 20 | 25 | 25 |
Income After Depreciation & Amortization | -2 | -5 | 2 | 0 | -2 |
Non-Operating Income | 1 | 4 | 5 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -2 | -2 | 7 | 0 | -2 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -2 | -2 | 7 | -1 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | -1 | 0 |
Net Income (GAAP) | -2 | -2 | 7 | -1 | -2 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1 | -4 | 3 | 1 | -1 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 1 | 1 | 2 |
Income After Depreciation & Amortization | -2 | -5 | 2 | 0 | -2 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 7.02 | 6.95 | 6.99 | 6.96 | 7.15 |
Diluted EPS Before Non-Recurring Items | -0.24 | -0.25 | 0.99 | -0.08 | -0.34 |
Diluted Net EPS (GAAP) | -0.26 | -0.29 | 0.99 | -0.16 | -0.25 |
Fiscal Year end for SunLink Health Systems, Inc falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 8.51 | 8.56 | 10.99 | 11.53 |
Cost Of Goods | NA | 5.08 | 5.09 | 6.32 | 6.07 |
Gross Profit | NA | 3.43 | 3.46 | 4.66 | 5.47 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.86 | 3.91 | 6.64 | 6.24 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.43 | -0.45 | -1.98 | -0.77 |
Non-Operating Income | NA | 0.03 | 0.02 | 0.54 | 0.04 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -0.40 | -0.43 | -1.44 | -0.73 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | -0.01 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.41 | -0.43 | -1.44 | -0.73 |
Extras & Discontinued Operations | NA | -2.67 | -0.92 | 0.01 | -0.04 |
Net Income (GAAP) | NA | -3.08 | -1.34 | -1.43 | -0.76 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 7.04 | 7.03 | 7.03 | 7.03 |
Diluted EPS Before Non-Recurring Items | NA | -0.06 | -0.06 | -0.20 | -0.10 |
Diluted Net EPS (GAAP) | NA | -0.44 | -0.19 | -0.21 | -0.11 |